Ionis Pharmaceuticals IONS Debt Securities Available For Sale And Equity Securities Fv Ni
Debt Securities Available For Sale And Equity Securities Fv Ni at other companies
Other financials
Where this comes from
Reported directly by Ionis Pharmaceuticals in its filing.
Tagged under the XBRL concept ions:DebtSecuritiesAvailableForSaleAndEquitySecuritiesFvNi.
The official record: Ionis Pharmaceuticals’s 10-Q, filed April 29, 2026, on SEC EDGAR. View the filing →
Ask your AI about Ionis Pharmaceuticals's debt securities available for sale and equity securities fv ni.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Ionis Pharmaceuticals's debt securities available for sale and equity securities fv ni?
- Ionis Pharmaceuticals (IONS) reported debt securities available for sale and equity securities fv ni of $1.83B in Q1 2026.
- How has Ionis Pharmaceuticals's debt securities available for sale and equity securities fv ni changed year-over-year?
- Ionis Pharmaceuticals's debt securities available for sale and equity securities fv ni decreased by 6.8% year-over-year, from $1.96B to $1.83B.
- What is the long-term trend for Ionis Pharmaceuticals's debt securities available for sale and equity securities fv ni?
- Over 5 years (2020 to 2025), Ionis Pharmaceuticals's debt securities available for sale and equity securities fv ni has grown at a 9.1% compound annual growth rate (CAGR), from $1.56B to $2.41B.
- What does debt securities available for sale and equity securities fv ni mean?
- The total current market value of all debt and equity investments.
- How do you interpret debt securities available for sale and equity securities fv ni?
- An increase indicates growth in the total value of the company's investment portfolio, enhancing its financial flexibility.
- How does debt securities available for sale and equity securities fv ni compare across companies?
- A standard measure for comparing the total investment scale of pharmaceutical companies.